{"id": "1364459009684561921", "creation": 1614147352.0, "user_id": "273819343", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 0, "quote_count": 0}}, "quoted": "1364450482698162176", "text": "Highly pleased to read that China's Drug Regulator has accepted CanSino\u2019s application for conditional market approval of its recombinant adenovirus vector #vaccine for #COVID19, the company said on Wed ... It is China's third vaccine candidate to apply for mass use!!!\n\n*** https://t.co/kQ233dXR0Z", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19"]}